| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.516 | 0.008 | 0.647 | Sigma receptor agonist | 0.545 0.006 DBMET03117 0.647 0.004 DBMET03118 | DBMET03118 | |
| 0.492 | 0.008 | 0.492 | Anesthetic general | 0.437 0.012 DBMET03117 0.367 0.021 DBMET03118 | ||
| 0.436 | 0.005 | 0.46 | Insulin sensitizer | 0.46 0.004 DBMET03117 0.313 0.013 DBMET03118 | DBMET03117 | |
| 0.443 | 0.02 | 0.576 | Platelet antagonist | 0.576 0.008 DBMET03117 0.53 0.011 DBMET03118 | DBMET03117 | |
| 0.433 | 0.042 | 0.633 | Antithrombotic | 0.633 0.013 DBMET03117 0.523 0.026 DBMET03118 | DBMET03117 | |
| 0.381 | 0.018 | 0.551 | Anticoagulant | 0.472 0.012 DBMET03117 0.551 0.008 DBMET03118 | DBMET03118 | |
| 0.36 | 0.041 | 0.472 | Interleukin 2 agonist | 0.472 0.012 DBMET03117 0.46 0.014 DBMET03118 | DBMET03117 | |
| 0.386 | 0.087 | 0.62 | 5 Hydroxytryptamine release inhibitor | 0.561 0.017 DBMET03117 0.62 0.009 DBMET03118 | DBMET03118 | |
| 0.327 | 0.044 | 0.406 | Insulysin inhibitor | 0.387 0.024 DBMET03117 0.406 0.021 DBMET03118 | DBMET03118 | |
| 0.299 | 0.048 | 0.389 | Interleukin antagonist | 0.389 0.032 DBMET03117 0.327 0.042 DBMET03118 | DBMET03117 | |
| 0.299 | 0.049 | 0.459 | Interleukin agonist | 0.423 0.016 DBMET03117 0.459 0.012 DBMET03118 | DBMET03118 | |
| 0.263 | 0.02 | 0.316 | Nav1.2 sodium channel blocker | 0.316 0.013 DBMET03117 0.297 0.015 DBMET03118 | DBMET03117 | |
| 0.246 | 0.005 | 0.409 | Trypsin inhibitor | 0.37 0.004 DBMET03117 0.409 0.004 DBMET03118 | DBMET03118 | |
| 0.275 | 0.042 | 0.4 | Platelet aggregation inhibitor | 0.4 0.018 DBMET03117 0.308 0.034 DBMET03118 | DBMET03117 | |
| 0.228 | 0.004 | 0.389 | Trypsin I inhibitor | 0.389 0.004 DBMET03117 0.356 0.004 DBMET03118 | DBMET03117 | |
| 0.217 | 0.004 | 0.357 | Neuraminidase (influenza) inhibitor | 0.258 0.004 DBMET03117 0.357 0.002 DBMET03118 | DBMET03118 | |
| 0.28 | 0.085 | 0.349 | Immunostimulant | 0.349 0.065 DBMET03117 0.34 0.067 DBMET03118 | DBMET03117 | |
| 0.222 | 0.026 | 0.222 | Anesthetic local | |||
| 0.241 | 0.052 | 0.331 | Platelet adhesion inhibitor | 0.331 0.025 DBMET03117 0.217 0.063 DBMET03118 | DBMET03117 | |
| 0.202 | 0.018 | 0.346 | Nav1.1 sodium channel blocker | 0.295 0.009 DBMET03117 0.346 0.005 DBMET03118 | DBMET03118 | |
| 0.179 | 0.004 | 0.327 | Maillard reaction inhibitor | 0.274 0.003 DBMET03117 0.327 0.003 DBMET03118 | DBMET03118 | |
| 0.249 | 0.081 | 0.302 | DNA damaging | 0.301 0.056 DBMET03117 0.302 0.056 DBMET03118 | DBMET03118 | |
| 0.17 | 0.005 | 0.311 | Neuraminidase inhibitor | 0.23 0.004 DBMET03117 0.311 0.003 DBMET03118 | DBMET03118 | |
| 0.165 | 0.006 | 0.176 | Kallikrein 1 inhibitor | 0.176 0.005 DBMET03117 0.167 0.006 DBMET03118 | DBMET03117 | |
| 0.158 | 0.003 | 0.158 | Epithelial sodium channel blocker | 0.112 0.005 DBMET03117 0.122 0.004 DBMET03118 | ||
| 0.157 | 0.006 | 0.438 | Urokinase inhibitor | 0.218 0.004 DBMET03117 0.438 0.003 DBMET03118 | DBMET03118 | |
| 0.175 | 0.03 | 0.235 | Cyclooxygenase 3 inhibitor | 0.235 0.01 DBMET03117 0.134 0.063 DBMET03118 | DBMET03117 | |
| 0.193 | 0.055 | 0.354 | Thrombolytic | 0.305 0.023 DBMET03117 0.354 0.016 DBMET03118 | DBMET03118 | |
| 0.161 | 0.027 | 0.292 | Mucolytic | 0.292 0.004 DBMET03117 0.227 0.009 DBMET03118 | DBMET03117 | |
| 0.157 | 0.026 | 0.157 | Mediator release inhibitor | 0.13 0.039 DBMET03117 0.126 0.042 DBMET03118 | ||
| 0.174 | 0.046 | 0.438 | Hemostatic | 0.408 0.007 DBMET03117 0.438 0.006 DBMET03118 | DBMET03118 | |
| 0.2 | 0.071 | 0.321 | Non-steroidal antiinflammatory agent | 0.321 0.024 DBMET03117 0.152 0.112 DBMET03118 | DBMET03117 | |
| 0.154 | 0.032 | 0.33 | Interleukin 8 antagonist | 0.33 0.004 DBMET03117 0.192 0.015 DBMET03118 | DBMET03117 | |
| 0.135 | 0.018 | 0.187 | Neuropeptide agonist | 0.155 0.012 DBMET03117 0.187 0.006 DBMET03118 | DBMET03118 | |
| 0.236 | 0.123 | 0.236 | Ca(v)3.3 blocker | 0.215 0.16 DBMET03118 | ||
| 0.125 | 0.013 | 0.255 | Plasmin inhibitor | 0.176 0.008 DBMET03117 0.255 0.005 DBMET03118 | DBMET03118 | |
| 0.119 | 0.008 | 0.151 | Kallikrein inhibitor | 0.123 0.008 DBMET03117 0.151 0.005 DBMET03118 | DBMET03118 | |
| 0.133 | 0.028 | 0.183 | Factor V inhibitor | 0.15 0.018 DBMET03117 0.183 0.008 DBMET03118 | DBMET03118 | |
| 0.123 | 0.017 | 0.182 | Thrombin inhibitor | 0.138 0.013 DBMET03117 0.182 0.008 DBMET03118 | DBMET03118 | |
| 0.148 | 0.047 | 0.184 | Alkylator | 0.172 0.036 DBMET03117 0.184 0.031 DBMET03118 | DBMET03118 | |
| 0.105 | 0.004 | 0.195 | Neuraminidase (Influenza A) inhibitor | 0.144 0.003 DBMET03117 0.195 0.002 DBMET03118 | DBMET03118 | |
| 0.215 | 0.116 | 0.215 | Transcription factor STAT3 inhibitor | 0.202 0.131 DBMET03118 | ||
| 0.111 | 0.013 | 0.22 | Plasminogen activator inhibitor | 0.159 0.006 DBMET03117 0.22 0.004 DBMET03118 | DBMET03118 | |
| 0.136 | 0.037 | 0.137 | Protease inhibitor | 0.137 0.036 DBMET03117 0.125 0.044 DBMET03118 | DBMET03117 | |
| 0.193 | 0.096 | 0.402 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.247 0.062 DBMET03117 0.402 0.014 DBMET03118 | DBMET03118 | |
| 0.112 | 0.015 | 0.249 | GP IIb/IIIa receptor antagonist | 0.245 0.005 DBMET03117 0.249 0.005 DBMET03118 | DBMET03118 | |
| 0.198 | 0.102 | 0.272 | Peptidyltransferase inhibitor | 0.223 0.073 DBMET03117 0.272 0.037 DBMET03118 | DBMET03118 | |
| 0.098 | 0.005 | 0.39 | Tryptase inhibitor | 0.171 0.004 DBMET03117 0.39 0.003 DBMET03118 | DBMET03118 | |
| 0.145 | 0.052 | 0.202 | DNA polymerase I inhibitor | 0.202 0.028 DBMET03117 0.164 0.042 DBMET03118 | DBMET03117 | |
| 0.103 | 0.014 | 0.178 | Protease activated receptor 1 antagonist | 0.132 0.009 DBMET03117 0.178 0.004 DBMET03118 | DBMET03118 | |
| 0.163 | 0.074 | 0.228 | Neurotensin receptor agonist | 0.203 0.033 DBMET03117 0.228 0.025 DBMET03118 | DBMET03118 | |
| 0.2 | 0.112 | 0.314 | Hypoglycemic | 0.314 0.048 DBMET03117 0.224 0.093 DBMET03118 | DBMET03117 | |
| 0.236 | 0.148 | 0.259 | Vasodilator, coronary | 0.259 0.125 DBMET03117 0.248 0.137 DBMET03118 | DBMET03117 | |
| 0.143 | 0.056 | 0.166 | Interleukin 4 antagonist | 0.149 0.05 DBMET03117 0.166 0.037 DBMET03118 | DBMET03118 | |
| 0.186 | 0.102 | 0.295 | Angiogenesis stimulant | 0.295 0.051 DBMET03117 0.29 0.053 DBMET03118 | DBMET03117 | |
| 0.121 | 0.042 | 0.173 | Gastric antisecretory | 0.143 0.03 DBMET03117 0.173 0.018 DBMET03118 | DBMET03118 | |
| 0.091 | 0.013 | 0.181 | Factor VIIa inhibitor | 0.116 0.01 DBMET03117 0.181 0.005 DBMET03118 | DBMET03118 | |
| 0.108 | 0.031 | 0.134 | Factor XII inhibitor | 0.134 0.017 DBMET03117 0.133 0.018 DBMET03118 | DBMET03117 | |
| 0.224 | 0.147 | 0.293 | Transcription factor NF kappa B inhibitor | 0.293 0.098 DBMET03117 0.214 0.155 DBMET03118 | DBMET03117 | |
| 0.146 | 0.072 | 0.201 | Neuropeptide Y1 antagonist | 0.151 0.064 DBMET03117 0.201 0.018 DBMET03118 | DBMET03118 | |
| 0.198 | 0.124 | 0.27 | Neuropeptide Y2 antagonist | 0.218 0.091 DBMET03117 0.27 0.039 DBMET03118 | DBMET03118 | |
| 0.114 | 0.042 | 0.239 | Nitric-oxide synthase inhibitor | 0.193 0.01 DBMET03117 0.239 0.005 DBMET03118 | DBMET03118 | |
| 0.087 | 0.016 | 0.119 | Factor Xa inhibitor | 0.119 0.011 DBMET03118 | DBMET03118 | |
| 0.101 | 0.034 | 0.144 | Histamine H2 receptor antagonist | 0.083 0.059 DBMET03117 0.144 0.011 DBMET03118 | DBMET03118 | |
| 0.077 | 0.014 | 0.141 | Factor X inhibitor | 0.086 0.013 DBMET03117 0.141 0.007 DBMET03118 | DBMET03118 | |
| 0.07 | 0.007 | 0.173 | Diamine oxidase inhibitor | 0.082 0.005 DBMET03117 0.173 0.003 DBMET03118 | DBMET03118 | |
| 0.134 | 0.073 | 0.193 | Bone formation stimulant | 0.193 0.038 DBMET03117 0.125 0.081 DBMET03118 | DBMET03117 | |
| 0.104 | 0.045 | 0.355 | NMDA receptor antagonist | 0.277 0.008 DBMET03117 0.355 0.005 DBMET03118 | DBMET03118 | |
| 0.093 | 0.035 | 0.537 | Histidine decarboxylase inhibitor | 0.489 0.003 DBMET03117 0.537 0.002 DBMET03118 | DBMET03118 | |
| 0.203 | 0.145 | 0.329 | Gastrin inhibitor | 0.329 0.017 DBMET03117 0.314 0.025 DBMET03118 | DBMET03117 | |
| 0.076 | 0.019 | 0.081 | Kallikrein 7 inhibitor | 0.081 0.013 DBMET03117 0.073 0.023 DBMET03118 | DBMET03117 | |
| 0.113 | 0.056 | 0.274 | Expectorant | 0.274 0.01 DBMET03117 0.215 0.018 DBMET03118 | DBMET03117 | |
| 0.079 | 0.023 | 0.079 | Nitric oxide donor | 0.061 0.047 DBMET03117 | ||
| 0.14 | 0.086 | 0.473 | Diuretic | 0.296 0.023 DBMET03117 0.473 0.009 DBMET03118 | DBMET03118 | |
| 0.077 | 0.027 | 0.137 | Protease activated receptor antagonist | 0.098 0.015 DBMET03117 0.137 0.006 DBMET03118 | DBMET03118 | |
| 0.183 | 0.134 | 0.183 | Spasmolytic | |||
| 0.107 | 0.06 | 0.271 | Aminopeptidase B inhibitor | 0.207 0.02 DBMET03117 0.271 0.011 DBMET03118 | DBMET03118 | |
| 0.137 | 0.09 | 0.232 | Phospholipase A2 inhibitor | 0.232 0.029 DBMET03117 0.143 0.081 DBMET03118 | DBMET03117 | |
| 0.052 | 0.009 | 0.086 | Trypsin II inhibitor | 0.062 0.007 DBMET03117 0.086 0.005 DBMET03118 | DBMET03118 | |
| 0.221 | 0.18 | 0.448 | Histamine release inhibitor | 0.448 0.051 DBMET03117 0.435 0.057 DBMET03118 | DBMET03117 | |
| 0.107 | 0.067 | 0.168 | Nav1.4 sodium channel blocker | 0.168 0.027 DBMET03117 0.161 0.029 DBMET03118 | DBMET03117 | |
| 0.138 | 0.098 | 0.237 | Growth hormone agonist | 0.237 0.047 DBMET03117 0.207 0.056 DBMET03118 | DBMET03117 | |
| 0.078 | 0.045 | 0.386 | NMDA 2 receptor antagonist | 0.178 0.012 DBMET03117 0.386 0.004 DBMET03118 | DBMET03118 | |
| 0.06 | 0.027 | 0.062 | Leukotriene B4 antagonist | 0.062 0.026 DBMET03117 | DBMET03117 | |
| 0.061 | 0.029 | 0.323 | NMDA 2A receptor antagonist | 0.154 0.007 DBMET03117 0.323 0.004 DBMET03118 | DBMET03118 | |
| 0.081 | 0.051 | 0.222 | Cell adhesion molecule inhibitor | 0.222 0.008 DBMET03117 0.191 0.01 DBMET03118 | DBMET03117 | |
| 0.135 | 0.106 | 0.143 | Arachidonic acid antagonist | 0.143 0.097 DBMET03117 | DBMET03117 | |
| 0.044 | 0.015 | 0.08 | Plasma kallikrein inhibitor | 0.06 0.009 DBMET03117 0.08 0.005 DBMET03118 | DBMET03118 | |
| 0.081 | 0.053 | 0.11 | Chymotrypsin inhibitor | 0.11 0.03 DBMET03117 0.084 0.049 DBMET03118 | DBMET03117 | |
| 0.03 | 0.005 | 0.103 | Neuraminidase (Influenza B) inhibitor | 0.042 0.003 DBMET03117 0.103 0.001 DBMET03118 | DBMET03118 | |
| 0.074 | 0.049 | 0.178 | Cathepsin G inhibitor | 0.178 0.018 DBMET03117 0.173 0.018 DBMET03118 | DBMET03117 | |
| 0.053 | 0.028 | 0.105 | Factor III inhibitor | 0.07 0.011 DBMET03117 0.105 0.004 DBMET03118 | DBMET03118 | |
| 0.032 | 0.008 | 0.038 | Complement factor 1r inhibitor | 0.036 0.006 DBMET03117 0.038 0.005 DBMET03118 | DBMET03118 | |
| 0.184 | 0.162 | 0.201 | Transcription factor STAT inhibitor | 0.201 0.137 DBMET03118 | DBMET03118 | |
| 0.06 | 0.039 | 0.064 | Gonadotropin-releasing hormone receptor agonist | 0.064 0.033 DBMET03118 | DBMET03118 | |
| 0.124 | 0.104 | 0.297 | Insulin secretagoues | 0.297 0.013 DBMET03117 0.294 0.013 DBMET03118 | DBMET03117 | |
| 0.029 | 0.009 | 0.312 | Integrin beta5 antagonist | 0.2 0.004 DBMET03117 0.312 0.003 DBMET03118 | DBMET03118 | |
| 0.046 | 0.029 | 0.094 | Complement C3a chemotactic receptor antagonist | 0.08 0.014 DBMET03117 0.094 0.01 DBMET03118 | DBMET03118 | |
| 0.06 | 0.045 | 0.356 | NMDA 2C receptor antagonist | 0.19 0.005 DBMET03117 0.356 0.004 DBMET03118 | DBMET03118 | |
| 0.081 | 0.066 | 0.081 | Vanilloid agonist | |||
| 0.114 | 0.103 | 0.122 | Vanilloid 1 agonist | 0.122 0.082 DBMET03117 | DBMET03117 | |
| 0.051 | 0.041 | 0.051 | Elastase inhibitor | |||
| 0.082 | 0.073 | 0.24 | Potassium channel (Ca-activated) activator | 0.24 0.009 DBMET03117 0.197 0.015 DBMET03118 | DBMET03117 | |
| 0.139 | 0.131 | 0.444 | Phospholipase C inhibitor | 0.259 0.023 DBMET03117 0.444 0.008 DBMET03118 | DBMET03118 | |
| 0.03 | 0.024 | 0.03 | Elastase 3A inhibitor | |||
| 0.03 | 0.024 | 0.03 | Elastase 3B inhibitor | |||
| 0.03 | 0.024 | 0.03 | Elastase 2B inhibitor | |||
| 0.08 | 0.074 | 0.082 | Interleukin 5 antagonist | 0.082 0.069 DBMET03118 | DBMET03118 | |
| 0.017 | 0.013 | 0.026 | Complement factor 1 inhibitor | 0.021 0.007 DBMET03117 0.026 0.005 DBMET03118 | DBMET03118 | |
| 0.017 | 0.016 | 0.225 | Integrin beta3 antagonist | 0.131 0.004 DBMET03117 0.225 0.004 DBMET03118 | DBMET03118 | |
| 0.097 | 0.096 | 0.242 | Cell adhesion inhibitor | 0.242 0.016 DBMET03117 0.205 0.023 DBMET03118 | DBMET03117 | |
| 0.018 | 0.018 | 0.115 | Vitronectin receptor antagonist | 0.115 0.004 DBMET03117 0.114 0.004 DBMET03118 | DBMET03117 | |
| 0.036 | 0.037 | 0.038 | Glucagon-like peptide 1 receptor antagonist | 0.038 0.031 DBMET03117 | DBMET03117 | |
| 0.015 | 0.018 | 0.037 | Sodium/hydrogen exchanger inhibitor | 0.018 0.011 DBMET03117 0.037 0.004 DBMET03118 | DBMET03118 | |
| 0.043 | 0.048 | 0.058 | Bombesin 2 receptor antagonist | 0.057 0.026 DBMET03117 0.058 0.025 DBMET03118 | DBMET03118 | |
| 0.034 | 0.041 | 0.06 | Integrin alpha5beta1 antagonist | 0.06 0.012 DBMET03117 0.06 0.012 DBMET03118 | DBMET03118 | |
| 0.029 | 0.036 | 0.23 | NMDA receptor subunit 3A antagonist | 0.168 0.005 DBMET03117 0.23 0.004 DBMET03118 | DBMET03118 | |
| 0.038 | 0.045 | 0.044 | Dihydrofolate reductase inhibitor | 0.044 0.028 DBMET03117 0.044 0.028 DBMET03118 | DBMET03118 | |
| 0.022 | 0.031 | 0.095 | Factor VII inhibitor | 0.041 0.014 DBMET03117 0.095 0.007 DBMET03118 | DBMET03118 | |
| 0.032 | 0.041 | 0.154 | Dihydropteroate synthase inhibitor | 0.07 0.008 DBMET03117 0.154 0.003 DBMET03118 | DBMET03118 | |
| 0.023 | 0.032 | 0.05 | Thrombin receptor antagonist | 0.032 0.016 DBMET03117 0.05 0.009 DBMET03118 | DBMET03118 | |
| 0.057 | 0.067 | 0.136 | Potassium channel large-conductance Ca-activated activator | 0.136 0.013 DBMET03117 0.09 0.029 DBMET03118 | DBMET03117 | |
| 0.012 | 0.022 | 0.022 | Prokineticin receptor 1 antagonist | 0.017 0.011 DBMET03117 0.022 0.005 DBMET03118 | DBMET03118 | |
| 0.057 | 0.068 | 0.129 | Potassium channel (ATP-sensitive) blocker | 0.091 0.02 DBMET03117 0.129 0.007 DBMET03118 | DBMET03118 | |
| 0.033 | 0.044 | 0.072 | Acid-sensing ion channel blocker | 0.049 0.017 DBMET03117 0.072 0.005 DBMET03118 | DBMET03118 | |
| 0.028 | 0.04 | 0.2 | Integrin antagonist | 0.2 0.007 DBMET03117 0.158 0.01 DBMET03118 | DBMET03117 | |
| 0.049 | 0.061 | 0.093 | Selectin antagonist | 0.093 0.03 DBMET03117 0.062 0.047 DBMET03118 | DBMET03117 | |
| 0.016 | 0.028 | 0.049 | Integrin alphaVbeta3 antagonist | 0.042 0.005 DBMET03117 0.049 0.005 DBMET03118 | DBMET03118 | |
| 0.021 | 0.033 | 0.029 | Bradykinin B2 receptor agonist | 0.029 0.019 DBMET03118 | DBMET03118 | |
| 0.021 | 0.039 | 0.046 | Complement factor 1s inhibitor | 0.035 0.005 DBMET03117 0.046 0.003 DBMET03118 | DBMET03118 | |
| 0.029 | 0.048 | 0.061 | Vascular adhesion protein 1 inhibitor | 0.061 0.009 DBMET03118 | DBMET03118 | |
| 0.09 | 0.109 | 0.145 | TRPA1 agonist | 0.145 0.035 DBMET03117 0.11 0.072 DBMET03118 | DBMET03117 | |
| 0.032 | 0.051 | 0.271 | NMDA receptor subunit 3B antagonist | 0.207 0.004 DBMET03117 0.271 0.004 DBMET03118 | DBMET03118 | |
| 0.033 | 0.053 | 0.053 | Neurotensin receptor antagonist | 0.041 0.036 DBMET03117 0.053 0.026 DBMET03118 | DBMET03118 | |
| 0.032 | 0.054 | 0.062 | Histamine H2 receptor agonist | 0.062 0.014 DBMET03118 | DBMET03118 | |
| 0.17 | 0.195 | 0.286 | Cholesterol antagonist | 0.286 0.101 DBMET03117 0.286 0.1 DBMET03118 | DBMET03118 | |
| 0.027 | 0.051 | 0.036 | Antibiotic Aminoglycoside-like | 0.036 0.025 DBMET03118 | DBMET03118 | |
| 0.004 | 0.028 | 0.021 | Integrin alphaVbeta5 antagonist | 0.021 0.004 DBMET03117 0.02 0.004 DBMET03118 | DBMET03117 | |
| 0.093 | 0.118 | 0.124 | Interleukin 2 antagonist | 0.124 0.039 DBMET03118 | DBMET03118 | |
| 0.016 | 0.043 | 0.133 | Lysine carboxypeptidase inhibitor | 0.065 0.005 DBMET03117 0.133 0.003 DBMET03118 | DBMET03118 | |
| 0.149 | 0.176 | 0.254 | Cardiotonic | 0.213 0.108 DBMET03117 0.254 0.08 DBMET03118 | DBMET03118 | |
| 0.041 | 0.068 | 0.161 | CXC chemokine 4 receptor antagonist | 0.069 0.037 DBMET03117 0.161 0.014 DBMET03118 | DBMET03118 | |
| 0.02 | 0.049 | 0.051 | Purinergic P2Y14 antagonist | 0.051 0.007 DBMET03118 | DBMET03118 | |
| 0.11 | 0.141 | 0.196 | Thiol protease inhibitor | 0.131 0.094 DBMET03117 0.196 0.04 DBMET03118 | DBMET03118 | |
| 0.07 | 0.101 | 0.15 | Urease inhibitor | 0.106 0.06 DBMET03117 0.15 0.023 DBMET03118 | DBMET03118 | |
| 0.013 | 0.045 | 0.019 | Tryptophan hydroxylase 1 inhibitor | 0.018 0.009 DBMET03117 0.019 0.009 DBMET03118 | DBMET03118 | |
| 0.075 | 0.11 | 0.152 | Glutamate release inhibitor | 0.109 0.031 DBMET03117 0.152 0.009 DBMET03118 | DBMET03118 | |
| 0.15 | 0.187 | 0.725 | Superoxide dismutase inhibitor | 0.462 0.017 DBMET03117 0.725 0.004 DBMET03118 | DBMET03118 | |
| 0.023 | 0.062 | 0.068 | Factor XI inhibitor | 0.035 0.022 DBMET03117 0.068 0.005 DBMET03118 | DBMET03118 | |
| 0.038 | 0.077 | 0.08 | Glucagon-like peptide 1 agonist | 0.08 0.035 DBMET03117 0.065 0.045 DBMET03118 | DBMET03117 | |
| 0.169 | 0.209 | 0.321 | Angiogenesis inhibitor | 0.262 0.114 DBMET03117 0.321 0.083 DBMET03118 | DBMET03118 | |
| 0.043 | 0.086 | 0.062 | Leukotriene antagonist | 0.062 0.048 DBMET03117 | DBMET03117 | |
| 0.008 | 0.052 | 0.077 | VLA-4 antagonist | 0.077 0.008 DBMET03117 0.047 0.014 DBMET03118 | DBMET03117 | |
| 0.079 | 0.126 | 0.125 | Folate antagonist | 0.104 0.057 DBMET03117 0.125 0.035 DBMET03118 | DBMET03118 | |
| 0.008 | 0.056 | 0.015 | Thyroid hormone alpha antagonist | 0.015 0.011 DBMET03117 | DBMET03117 | |
| 0.009 | 0.058 | 0.017 | Factor IX inhibitor | 0.017 0.014 DBMET03118 | DBMET03118 | |
| 0.03 | 0.086 | 0.065 | Lysophosphatidic acid 3 receptor antagonist | 0.065 0.018 DBMET03117 0.047 0.04 DBMET03118 | DBMET03117 | |
| 0.009 | 0.065 | 0.029 | Retinoid X beta receptor agonist | 0.029 0.009 DBMET03117 0.023 0.012 DBMET03118 | DBMET03117 | |
| 0.01 | 0.068 | 0.032 | Retinoid X gamma receptor agonist | 0.032 0.009 DBMET03117 0.029 0.011 DBMET03118 | DBMET03117 | |
| 0.024 | 0.082 | 0.05 | Tryptophan 5 hydroxylase inhibitor | 0.049 0.005 DBMET03117 0.05 0.005 DBMET03118 | DBMET03118 | |
| 0.051 | 0.109 | 0.155 | Ornithine decarboxylase inhibitor | 0.125 0.022 DBMET03117 0.155 0.01 DBMET03118 | DBMET03118 | |
| 0.124 | 0.185 | 0.178 | Free radical scavenger | 0.178 0.117 DBMET03117 | DBMET03117 | |
| 0.093 | 0.154 | 0.292 | Cell wall synthesis inhibitor | 0.186 0.036 DBMET03117 0.292 0.01 DBMET03118 | DBMET03118 | |
| 0.016 | 0.078 | 0.032 | Calcitonin receptor agonist | 0.032 0.025 DBMET03118 | DBMET03118 | |
| 0.01 | 0.076 | 0.022 | Integrin alphaVbeta1 antagonist | 0.022 0.01 DBMET03117 0.019 0.013 DBMET03118 | DBMET03117 | |
| 0.202 | 0.27 | 0.339 | Calcium channel L-type activator | 0.297 0.16 DBMET03117 0.339 0.126 DBMET03118 | DBMET03118 | |
| 0.051 | 0.121 | 0.141 | Histamine N-methyltransferase inhibitor | 0.076 0.071 DBMET03117 0.141 0.018 DBMET03118 | DBMET03118 | |
| 0.07 | 0.14 | 0.281 | AMP-activated protein kinase stimulant | 0.215 0.009 DBMET03117 0.281 0.005 DBMET03118 | DBMET03118 | |
| 0.057 | 0.131 | 0.082 | Glutathione S-transferase inhibitor | 0.082 0.059 DBMET03117 0.081 0.059 DBMET03118 | DBMET03117 | |
| 0.165 | 0.24 | 0.211 | Apoptosis antagonist | 0.211 0.166 DBMET03117 | DBMET03117 | |
| 0.065 | 0.141 | 0.138 | Bile acid receptor antagonist | 0.138 0.01 DBMET03117 0.106 0.038 DBMET03118 | DBMET03117 | |
| 0.105 | 0.182 | 0.133 | Hepatoprotectant | 0.133 0.13 DBMET03117 | DBMET03117 | |
| 0.119 | 0.196 | 0.199 | Heat shock protein 70 antagonist | 0.147 0.052 DBMET03117 0.199 0.006 DBMET03118 | DBMET03118 | |
| 0.019 | 0.098 | 0.047 | Carboxypeptidase B inhibitor | 0.037 0.016 DBMET03117 0.047 0.008 DBMET03118 | DBMET03118 | |
| 0.033 | 0.114 | 0.082 | Heparanase inhibitor | 0.082 0.006 DBMET03117 0.069 0.013 DBMET03118 | DBMET03117 | |
| 0.021 | 0.104 | 0.067 | Retinoic acid alpha receptor agonist | 0.04 0.026 DBMET03117 0.067 0.007 DBMET03118 | DBMET03118 | |
| 0.031 | 0.114 | 0.112 | Factor IXa inhibitor | 0.052 0.034 DBMET03117 0.112 0.007 DBMET03118 | DBMET03118 | |
| 0.122 | 0.206 | 0.173 | Antioxidant | 0.173 0.139 DBMET03117 | DBMET03117 | |
| 0.078 | 0.165 | 0.216 | Cathepsin H inhibitor | 0.154 0.043 DBMET03117 0.216 0.019 DBMET03118 | DBMET03118 | |
| 0.034 | 0.121 | 0.178 | CD45 antagonist | 0.077 0.013 DBMET03117 0.178 0.005 DBMET03118 | DBMET03118 | |
| 0.026 | 0.115 | 0.331 | Argininosuccinate synthase inhibitor | 0.169 0.01 DBMET03117 0.331 0.003 DBMET03118 | DBMET03118 | |
| 0.002 | 0.091 | 0.012 | Carboxypeptidase B2 inhibitor | 0.012 0.007 DBMET03118 | DBMET03118 | |
| 0.019 | 0.109 | 0.067 | Adenosine deaminase inhibitor | 0.044 0.036 DBMET03117 0.067 0.015 DBMET03118 | DBMET03118 | |
| 0.013 | 0.105 | 0.032 | Vanilloid 2 agonist | 0.032 0.008 DBMET03118 | DBMET03118 | |
| 0.007 | 0.099 | 0.029 | Retinoic acid alpha receptor antagonist | 0.029 0.007 DBMET03118 | DBMET03118 | |
| 0.018 | 0.114 | 0.227 | Ornithine carbamoyltransferase inhibitor | 0.08 0.022 DBMET03117 0.227 0.006 DBMET03118 | DBMET03118 | |
| 0.057 | 0.153 | 0.234 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.226 0.012 DBMET03117 0.234 0.011 DBMET03118 | DBMET03118 | |
| 0.01 | 0.108 | 0.024 | Retinoic acid beta receptor agonist | 0.024 0.008 DBMET03118 | DBMET03118 | |
| 0.053 | 0.151 | 0.164 | Falcipain 3 inhibitor | 0.164 0.03 DBMET03118 | DBMET03118 | |
| 0.043 | 0.142 | 0.081 | Somatostatin 1 agonist | 0.081 0.05 DBMET03118 | DBMET03118 | |
| 0.048 | 0.147 | 0.19 | Keratolytic | 0.144 0.015 DBMET03117 0.19 0.009 DBMET03118 | DBMET03118 | |
| 0.009 | 0.11 | 0.035 | Prostacyclin antagonist | 0.035 0.021 DBMET03117 | DBMET03117 | |
| 0.001 | 0.103 | 0.008 | Mannitol 2-dehydrogenase inhibitor | 0.008 0.006 DBMET03118 | DBMET03118 | |
| 0.027 | 0.131 | 0.051 | Protein kinase C eta inhibitor | 0.051 0.043 DBMET03118 | DBMET03118 | |
| 0.078 | 0.184 | 0.126 | Antibacterial (Helicobacter pylori) | 0.119 0.083 DBMET03117 0.126 0.073 DBMET03118 | DBMET03118 | |
| 0.003 | 0.11 | 0.013 | Imidazoline I2 receptor antagonist | 0.013 0.005 DBMET03118 | DBMET03118 | |
| 0.006 | 0.113 | 0.08 | Arginase inhibitor | 0.044 0.019 DBMET03117 0.08 0.006 DBMET03118 | DBMET03118 | |
| 0.044 | 0.151 | 0.092 | Adrenaline agonist | 0.072 0.069 DBMET03117 0.092 0.044 DBMET03118 | DBMET03118 | |
| 0.048 | 0.157 | 0.124 | Inducible nitric-oxide synthase inhibitor | 0.11 0.03 DBMET03117 0.124 0.023 DBMET03118 | DBMET03118 | |
| 0.044 | 0.154 | 0.12 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.072 0.054 DBMET03117 0.12 0.006 DBMET03118 | DBMET03118 | |
| 0.01 | 0.12 | 0.027 | Retinoic acid receptor agonist | 0.027 0.012 DBMET03118 | DBMET03118 | |
| 0.034 | 0.146 | 0.234 | Glutamate decarboxylase inhibitor | 0.179 0.009 DBMET03117 0.234 0.005 DBMET03118 | DBMET03118 | |
| 0.024 | 0.136 | 0.065 | Carnitine palmitoyltransferase 1B inhibitor | 0.065 0.014 DBMET03117 0.046 0.036 DBMET03118 | DBMET03117 | |
| 0.017 | 0.129 | 0.074 | Factor XIa inhibitor | 0.074 0.009 DBMET03118 | DBMET03118 | |
| 0.09 | 0.202 | 0.147 | DNA methyltransferase I inhibitor | 0.147 0.107 DBMET03118 | DBMET03118 | |
| 0.005 | 0.118 | 0.061 | Prostaglandin D2 antagonist | 0.061 0.005 DBMET03117 | DBMET03117 | |
| 0.054 | 0.167 | 0.51 | Ferrochelatase inhibitor | 0.252 0.013 DBMET03117 0.51 0.002 DBMET03118 | DBMET03118 | |
| 0.061 | 0.175 | 0.098 | Hematopoietic | 0.098 0.038 DBMET03118 | DBMET03118 | |
| 0.058 | 0.173 | 0.191 | Adenylate cyclase inhibitor | 0.154 0.042 DBMET03117 0.191 0.027 DBMET03118 | DBMET03118 | |
| 0.011 | 0.134 | 0.026 | Retinoic acid gamma receptor agonist | 0.026 0.009 DBMET03118 | DBMET03118 | |
| 0.017 | 0.142 | 0.093 | Mannosidase inhibitor | 0.053 0.022 DBMET03117 0.093 0.006 DBMET03118 | DBMET03118 | |
| 0.006 | 0.132 | 0.025 | Retinoic acid receptor antagonist | 0.025 0.008 DBMET03118 | DBMET03118 | |
| 0.004 | 0.131 | 0.012 | Retinoic acid receptor gamma antagonist | 0.012 0.008 DBMET03118 | DBMET03118 | |
| 0.101 | 0.228 | 0.184 | Lipocortins synthesis antagonist | 0.138 0.125 DBMET03117 0.184 0.067 DBMET03118 | DBMET03118 | |
| 0.072 | 0.202 | 0.166 | Psychostimulant | 0.166 0.103 DBMET03117 0.146 0.12 DBMET03118 | DBMET03117 | |
| 0.003 | 0.132 | 0.013 | Retinoic acid beta receptor antagonist | 0.013 0.007 DBMET03118 | DBMET03118 | |
| 0.112 | 0.242 | 0.195 | Cyclic AMP phosphodiesterase inhibitor | 0.195 0.097 DBMET03117 0.157 0.14 DBMET03118 | DBMET03117 | |
| 0.011 | 0.142 | 0.069 | NMDA 2D receptor antagonist | 0.069 0.005 DBMET03118 | DBMET03118 | |
| 0.01 | 0.141 | 0.018 | Potassium channel (Inward rectifier) 11 blocker | 0.018 0.012 DBMET03118 | DBMET03118 | |
| 0.052 | 0.184 | 0.117 | Anabolic | 0.111 0.049 DBMET03117 0.117 0.043 DBMET03118 | DBMET03118 | |
| 0.004 | 0.137 | 0.02 | Carbonic anhydrase X inhibitor | 0.02 0.009 DBMET03118 | DBMET03118 | |
| 0.004 | 0.137 | 0.02 | Carbonic anhydrase VIII inhibitor | 0.02 0.009 DBMET03118 | DBMET03118 | |
| 0.015 | 0.15 | 0.033 | Dipeptidyl peptidase II inhibitor | 0.033 0.022 DBMET03118 | DBMET03118 | |
| 0.063 | 0.202 | 0.205 | Adenylate kinase inhibitor | 0.151 0.026 DBMET03117 0.205 0.014 DBMET03118 | DBMET03118 | |
| 0.088 | 0.228 | 0.161 | Melanin inhibitor | 0.161 0.068 DBMET03117 0.141 0.095 DBMET03118 | DBMET03117 | |
| 0.029 | 0.17 | 0.069 | Sphingosine kinase inhibitor | 0.068 0.027 DBMET03117 0.069 0.026 DBMET03118 | DBMET03118 | |
| 0.054 | 0.197 | 0.2 | Protein kinase C gamma inhibitor | 0.2 0.014 DBMET03118 | DBMET03118 | |
| 0.022 | 0.165 | 0.062 | Peroxisome proliferator-activated receptor gamma agonist | 0.062 0.056 DBMET03117 | DBMET03117 | |
| 0.008 | 0.151 | 0.052 | Carbonic anhydrase IV inhibitor | 0.052 0.023 DBMET03118 | DBMET03118 | |
| 0.089 | 0.232 | 0.138 | Interleukin 6 antagonist | 0.138 0.108 DBMET03117 | DBMET03117 | |
| 0.014 | 0.158 | 0.034 | Peroxisome proliferator-activated receptor delta antagonist | 0.034 0.022 DBMET03117 | DBMET03117 | |
| 0.054 | 0.2 | 0.099 | ABCA1 expression enhancer | 0.099 0.051 DBMET03117 | DBMET03117 | |
| 0.01 | 0.162 | 0.092 | Carbonic anhydrase I inhibitor | 0.092 0.02 DBMET03118 | DBMET03118 | |
| 0.06 | 0.211 | 0.112 | Cyclooxygenase inhibitor | 0.112 0.109 DBMET03117 | DBMET03117 | |
| 0.084 | 0.235 | 0.143 | DNA methylase inhibitor | 0.143 0.124 DBMET03118 | DBMET03118 | |
| 0.106 | 0.261 | 0.165 | Catenin beta inhibitor | 0.165 0.075 DBMET03117 0.16 0.085 DBMET03118 | DBMET03117 | |
| 0.017 | 0.173 | 0.119 | Acyl-CoA dehydrogenase inhibitor | 0.119 0.013 DBMET03118 | DBMET03118 | |
| 0.033 | 0.191 | 0.092 | Monophenol monooxygenase inhibitor | 0.092 0.082 DBMET03118 | DBMET03118 | |
| 0.026 | 0.185 | 0.071 | Botulinum neurotoxin type A inhibitor | 0.068 0.027 DBMET03117 0.071 0.024 DBMET03118 | DBMET03118 | |
| 0.097 | 0.256 | 0.201 | ATPase inhibitor | 0.185 0.052 DBMET03117 0.201 0.036 DBMET03118 | DBMET03118 | |
| 0.012 | 0.172 | 0.073 | Carbonic anhydrase inhibitor | 0.073 0.038 DBMET03118 | DBMET03118 | |
| 0.01 | 0.172 | 0.071 | Carbonic anhydrase II inhibitor | 0.071 0.029 DBMET03118 | DBMET03118 | |
| 0.051 | 0.214 | 0.108 | Cyclooxygenase 1 inhibitor | 0.108 0.092 DBMET03117 | DBMET03117 | |
| 0.006 | 0.169 | 0.043 | Endothelial nitric-oxide synthase inhibitor | 0.043 0.012 DBMET03118 | DBMET03118 | |
| 0.071 | 0.238 | 0.11 | Sphingosine 1-phosphate receptor 4 antagonist | 0.11 0.093 DBMET03118 | DBMET03118 | |
| 0.017 | 0.187 | 0.041 | Sphingosine kinase 1 inhibitor | 0.039 0.033 DBMET03117 0.041 0.03 DBMET03118 | DBMET03118 | |
| 0.006 | 0.178 | 0.067 | Carbonic anhydrase XII inhibitor | 0.067 0.03 DBMET03118 | DBMET03118 | |
| 0.034 | 0.208 | 0.065 | Telomerase inhibitor | 0.065 0.058 DBMET03118 | DBMET03118 | |
| 0.038 | 0.212 | 0.062 | Histone deacetylase SIRT3 inhibitor | 0.062 0.045 DBMET03118 | DBMET03118 | |
| 0.034 | 0.21 | 0.183 | Glutamate dehydrogenase inhibitor | 0.073 0.052 DBMET03117 0.183 0.011 DBMET03118 | DBMET03118 | |
| 0.005 | 0.183 | 0.052 | Uridine phosphorylase inhibitor | 0.052 0.008 DBMET03118 | DBMET03118 | |
| 0.019 | 0.197 | 0.042 | Glutamate (mGluR8) antagonist | 0.036 0.025 DBMET03117 0.042 0.014 DBMET03118 | DBMET03118 | |
| 0.159 | 0.343 | 0.402 | Cyclophilin D inhibitor | 0.402 0.09 DBMET03117 0.25 0.213 DBMET03118 | DBMET03117 | |
| 0.002 | 0.186 | 0.012 | Carbonic anhydrase XI inhibitor | 0.012 0.009 DBMET03118 | DBMET03118 | |
| 0.007 | 0.192 | 0.055 | Kainate receptor antagonist | 0.039 0.03 DBMET03117 0.055 0.019 DBMET03118 | DBMET03118 | |
| 0.003 | 0.19 | 0.04 | AMPA 1 receptor antagonist | 0.04 0.014 DBMET03118 | DBMET03118 | |
| 0.034 | 0.221 | 0.059 | Leukotriene C antagonist | 0.059 0.03 DBMET03117 | DBMET03117 | |
| 0.117 | 0.307 | 0.343 | Vasodilator, peripheral | 0.288 0.103 DBMET03117 0.343 0.077 DBMET03118 | DBMET03118 | |
| 0.02 | 0.21 | 0.117 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.044 0.024 DBMET03117 0.117 0.002 DBMET03118 | DBMET03118 | |
| 0.013 | 0.203 | 0.131 | Prostaglandin antagonist | 0.131 0.012 DBMET03117 | DBMET03117 | |
| 0.022 | 0.213 | 0.038 | Leukotriene C4 antagonist | 0.038 0.029 DBMET03117 | DBMET03117 | |
| 0.05 | 0.242 | 0.507 | Alpha-N-acetylglucosaminidase inhibitor | 0.159 0.05 DBMET03117 0.507 0.005 DBMET03118 | DBMET03118 | |
| 0.036 | 0.228 | 0.118 | Carbonic anhydrase VI inhibitor | 0.118 0.03 DBMET03118 | DBMET03118 | |
| 0.021 | 0.214 | 0.073 | Carbonic anhydrase VA inhibitor | 0.073 0.043 DBMET03118 | DBMET03118 | |
| 0.13 | 0.324 | 0.231 | Tyrosine 3 hydroxylase inhibitor | 0.231 0.089 DBMET03117 0.231 0.089 DBMET03118 | DBMET03118 | |
| 0.03 | 0.225 | 0.066 | DNA helicase inhibitor | 0.066 0.02 DBMET03117 | DBMET03117 | |
| 0.132 | 0.33 | 0.448 | Antibacterial | 0.284 0.147 DBMET03117 0.448 0.058 DBMET03118 | DBMET03118 | |
| 0.042 | 0.242 | 0.061 | Calcium channel P-type blocker | 0.061 0.055 DBMET03118 | DBMET03118 | |
| 0.026 | 0.226 | 0.106 | 5 Hydroxytryptamine 3 agonist | 0.106 0.013 DBMET03118 | DBMET03118 | |
| 0.073 | 0.276 | 0.148 | Hypolipemic | 0.148 0.138 DBMET03117 | DBMET03117 | |
| 0.122 | 0.327 | 0.317 | Sodium/bile acid cotransporter inhibitor | 0.317 0.065 DBMET03117 | DBMET03117 | |
| 0.032 | 0.238 | 0.08 | Adenine nucleotide translocase inhibitor | 0.08 0.009 DBMET03118 | DBMET03118 | |
| 0.045 | 0.255 | 0.128 | Carbonic anhydrase III inhibitor | 0.128 0.039 DBMET03118 | DBMET03118 | |
| 0.05 | 0.261 | 0.213 | Carbonic anhydrase XV inhibitor | 0.213 0.016 DBMET03118 | DBMET03118 | |
| 0.04 | 0.257 | 0.122 | Protein kinase C zeta inhibitor | 0.122 0.031 DBMET03118 | DBMET03118 | |
| 0.017 | 0.235 | 0.066 | Carbonic anhydrase V inhibitor | 0.066 0.047 DBMET03118 | DBMET03118 | |
| 0.006 | 0.224 | 0.031 | Retinoid X receptor agonist | 0.031 0.028 DBMET03117 | DBMET03117 | |
| 0.005 | 0.224 | 0.068 | Carbonic anhydrase IX inhibitor | 0.068 0.033 DBMET03118 | DBMET03118 | |
| 0.015 | 0.235 | 0.043 | Histamine H1 receptor agonist | 0.043 0.032 DBMET03118 | DBMET03118 | |
| 0.037 | 0.258 | 0.239 | HIV-1 integrase (Overall Integration) inhibitor | 0.179 0.016 DBMET03117 0.239 0.005 DBMET03118 | DBMET03118 | |
| 0.016 | 0.238 | 0.228 | Biliverdin reductase inhibitor | 0.062 0.039 DBMET03117 0.228 0.005 DBMET03118 | DBMET03118 | |
| 0.019 | 0.245 | 0.146 | Phenylalanine 4-hydroxylase inhibitor | 0.083 0.036 DBMET03117 0.146 0.012 DBMET03118 | DBMET03118 | |
| 0.04 | 0.27 | 0.235 | Triose-phosphate isomerase inhibitor | 0.098 0.05 DBMET03117 0.235 0.008 DBMET03118 | DBMET03118 | |
| 0.009 | 0.243 | 0.062 | Carbonic anhydrase VB inhibitor | 0.062 0.034 DBMET03118 | DBMET03118 | |
| 0.023 | 0.258 | 0.112 | Aminopeptidase I inhibitor | 0.069 0.055 DBMET03117 0.112 0.022 DBMET03118 | DBMET03118 | |
| 0.033 | 0.27 | 0.181 | Glutamate receptor antagonist | 0.105 0.091 DBMET03117 0.181 0.032 DBMET03118 | DBMET03118 | |
| 0.023 | 0.263 | 0.113 | NMDA receptor agonist | 0.064 0.041 DBMET03117 0.113 0.015 DBMET03118 | DBMET03118 | |
| 0.064 | 0.309 | 0.527 | Aldehyde oxidase inhibitor | 0.16 0.13 DBMET03117 0.527 0.029 DBMET03118 | DBMET03118 | |
| 0.005 | 0.25 | 0.058 | Phosphoglycerate kinase inhibitor | 0.058 0.012 DBMET03118 | DBMET03118 | |
| 0.013 | 0.258 | 0.103 | NMDA receptor glycine site agonist | 0.103 0.015 DBMET03118 | DBMET03118 | |
| 0.007 | 0.253 | 0.029 | Calcium-sensing receptor agonist | 0.029 0.015 DBMET03118 | DBMET03118 | |
| 0.016 | 0.265 | 0.134 | Catalase inhibitor | 0.079 0.048 DBMET03117 0.134 0.03 DBMET03118 | DBMET03118 | |
| 0.026 | 0.277 | 0.08 | Secretase beta inhibitor | 0.08 0.037 DBMET03118 | DBMET03118 | |
| 0.033 | 0.285 | 0.08 | Neuropeptide Y antagonist | 0.08 0.058 DBMET03118 | DBMET03118 | |
| 0.019 | 0.272 | 0.061 | Carbonic anhydrase stimulant | 0.061 0.039 DBMET03118 | DBMET03118 | |
| 0.091 | 0.347 | 0.333 | DNA synthesis inhibitor | 0.208 0.111 DBMET03117 0.333 0.034 DBMET03118 | DBMET03118 | |
| 0.067 | 0.325 | 0.125 | Adenylate cyclase stimulant | 0.122 0.12 DBMET03117 0.125 0.114 DBMET03118 | DBMET03118 | |
| 0.034 | 0.296 | 0.201 | 5 Hydroxytryptamine 3A agonist | 0.201 0.015 DBMET03118 | DBMET03118 | |
| 0.018 | 0.284 | 0.068 | Sphingosine kinase 2 inhibitor | 0.068 0.023 DBMET03118 | DBMET03118 | |
| 0.03 | 0.297 | 0.128 | M17 leucyl aminopeptidase inhibitor | 0.103 0.097 DBMET03117 0.128 0.071 DBMET03118 | DBMET03118 | |
| 0.018 | 0.285 | 0.052 | Sphingosine 1-phosphate receptor 5 agonist | 0.052 0.042 DBMET03117 | DBMET03117 | |
| 0.045 | 0.313 | 0.143 | D-Ala-D-Ala ligase inhibitor | 0.088 0.048 DBMET03117 0.143 0.006 DBMET03118 | DBMET03118 | |
| 0.008 | 0.276 | 0.039 | Angiotensin AT1 receptor antagonist | 0.039 0.036 DBMET03118 | DBMET03118 | |
| 0.036 | 0.305 | 0.09 | Xanthine oxidase inhibitor | 0.09 0.071 DBMET03118 | DBMET03118 | |
| 0.07 | 0.34 | 0.28 | Succinate dehydrogenase inhibitor | 0.184 0.063 DBMET03117 0.28 0.014 DBMET03118 | DBMET03118 | |
| 0.012 | 0.283 | 0.306 | Alcohol oxidase inhibitor | 0.055 0.04 DBMET03117 0.306 0.004 DBMET03118 | DBMET03118 | |
| 0.023 | 0.297 | 0.135 | GABA aminotransferase inhibitor | 0.074 0.055 DBMET03117 0.135 0.011 DBMET03118 | DBMET03118 | |
| 0.007 | 0.286 | 0.032 | Retinoid X alpha receptor agonist | 0.032 0.027 DBMET03117 | DBMET03117 | |
| 0.016 | 0.295 | 0.066 | Na+ K+ transporting ATPase inhibitor | 0.066 0.064 DBMET03118 | DBMET03118 | |
| 0.035 | 0.315 | 0.093 | GABA B receptor agonist | 0.084 0.035 DBMET03117 0.093 0.022 DBMET03118 | DBMET03118 | |
| 0.012 | 0.293 | 0.045 | Glutamate (mGluR3) agonist | 0.045 0.007 DBMET03118 | DBMET03118 | |
| 0.069 | 0.35 | 0.153 | Interferon gamma antagonist | 0.124 0.123 DBMET03117 0.153 0.074 DBMET03118 | DBMET03118 | |
| 0.075 | 0.361 | 0.178 | Sphingosine 1-phosphate receptor 5 antagonist | 0.168 0.036 DBMET03117 0.178 0.026 DBMET03118 | DBMET03118 | |
| 0.007 | 0.297 | 0.037 | Nicotinic acid receptor 2 agonist | 0.037 0.024 DBMET03118 | DBMET03118 | |
| 0.022 | 0.319 | 0.117 | Purinergic P2X1 antagonist | 0.061 0.042 DBMET03117 0.117 0.012 DBMET03118 | DBMET03118 | |
| 0.02 | 0.316 | 0.08 | Carbonic anhydrase XIII inhibitor | 0.08 0.05 DBMET03118 | DBMET03118 | |
| 0.047 | 0.344 | 0.449 | Peroxidase inhibitor | 0.246 0.048 DBMET03117 0.449 0.014 DBMET03118 | DBMET03118 | |
| 0.011 | 0.313 | 0.125 | Phosphofructokinase-1 inhibitor | 0.125 0.024 DBMET03118 | DBMET03118 | |
| 0.015 | 0.317 | 0.064 | Glutamate (mGluR8) agonist | 0.038 0.027 DBMET03117 0.064 0.006 DBMET03118 | DBMET03118 | |
| 0.011 | 0.315 | 0.048 | Membrane dipeptidase inhibitor | 0.048 0.018 DBMET03118 | DBMET03118 | |
| 0.012 | 0.318 | 0.057 | Potassium channel (Inward rectifier) blocker | 0.057 0.026 DBMET03118 | DBMET03118 | |
| 0.056 | 0.363 | 0.143 | Sphingosine 1-phosphate receptor 2 antagonist | 0.143 0.051 DBMET03117 0.132 0.069 DBMET03118 | DBMET03117 | |
| 0.006 | 0.315 | 0.027 | Retinoid X gamma receptor antagonist | 0.027 0.02 DBMET03118 | DBMET03118 | |
| 0.037 | 0.349 | 0.188 | LIM domain kinase 1 inhibitor | 0.188 0.069 DBMET03118 | DBMET03118 | |
| 0.014 | 0.327 | 0.152 | Aconitate hydratase inhibitor | 0.057 0.029 DBMET03117 0.152 0.004 DBMET03118 | DBMET03118 | |
| 0.014 | 0.329 | 0.069 | Sphingosine 1-phosphate receptor 4 agonist | 0.069 0.046 DBMET03117 | DBMET03117 | |
| 0.002 | 0.318 | 0.032 | Kainate receptor 1 antagonist | 0.032 0.009 DBMET03118 | DBMET03118 | |
| 0.047 | 0.364 | 0.118 | Histone deacetylase SIRT1 inhibitor | 0.118 0.094 DBMET03118 | DBMET03118 | |
| 0.04 | 0.358 | 0.138 | DOPA decarboxylase inhibitor | 0.138 0.028 DBMET03117 0.131 0.034 DBMET03118 | DBMET03117 | |
| 0.036 | 0.354 | 0.142 | Pyruvate kinase inhibitor | 0.142 0.122 DBMET03118 | DBMET03118 | |
| 0.027 | 0.345 | 0.17 | Cystathionine beta-synthase inhibitor | 0.112 0.064 DBMET03117 0.17 0.033 DBMET03118 | DBMET03118 | |
| 0.007 | 0.333 | 0.018 | Methylmalonyl-CoA mutase inhibitor | 0.018 0.015 DBMET03118 | DBMET03118 | |
| 0.012 | 0.343 | 0.034 | Retinoid X alpha receptor antagonist | 0.034 0.023 DBMET03118 | DBMET03118 | |
| 0.026 | 0.36 | 0.44 | GABA C receptor agonist | 0.219 0.017 DBMET03117 0.44 0.004 DBMET03118 | DBMET03118 | |
| 0.009 | 0.345 | 0.064 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.064 0.035 DBMET03118 | DBMET03118 | |
| 0.005 | 0.343 | 0.046 | Fumarate hydratase inhibitor | 0.046 0.015 DBMET03118 | DBMET03118 | |
| 0.012 | 0.353 | 0.053 | Alpha-mannosidase inhibitor | 0.053 0.038 DBMET03118 | DBMET03118 | |
| 0.017 | 0.358 | 0.056 | Glutamate (mGluR4) antagonist | 0.056 0.016 DBMET03118 | DBMET03118 | |
| 0.012 | 0.357 | 0.038 | Retinoid X receptor antagonist | 0.038 0.027 DBMET03118 | DBMET03118 | |
| 0.013 | 0.358 | 0.054 | AICAR transformylase inhibitor | 0.054 0.018 DBMET03118 | DBMET03118 | |
| 0.013 | 0.362 | 0.12 | Check point kinase 2 inhibitor | 0.12 0.049 DBMET03118 | DBMET03118 | |
| 0.013 | 0.37 | 0.259 | Porphobilinogen synthase inhibitor | 0.073 0.053 DBMET03117 0.259 0.007 DBMET03118 | DBMET03118 | |
| 0.001 | 0.359 | 0.012 | Glutamate (mGluR6) agonist | 0.012 0.009 DBMET03118 | DBMET03118 | |
| 0.019 | 0.377 | 0.064 | Glutamate (mGluR7) antagonist | 0.064 0.054 DBMET03118 | DBMET03118 | |
| 0.034 | 0.396 | 0.081 | Granulocyte macrophage colony stimulating factor agonist | 0.081 0.071 DBMET03118 | DBMET03118 | |
| 0.058 | 0.423 | 0.177 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.177 0.035 DBMET03118 | DBMET03118 | |
| 0.048 | 0.416 | 0.196 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.196 0.077 DBMET03118 | DBMET03118 | |
| 0.025 | 0.392 | 0.176 | UDP-glucose 4-epimerase inhibitor | 0.176 0.022 DBMET03118 | DBMET03118 | |
| 0.032 | 0.404 | 0.175 | NADH dehydrogenase inhibitor | 0.175 0.013 DBMET03118 | DBMET03118 | |
| 0.026 | 0.402 | 0.098 | Glutamate (mGluR6) antagonist | 0.062 0.059 DBMET03117 0.098 0.011 DBMET03118 | DBMET03118 | |
| 0.108 | 0.49 | 0.312 | 5 Hydroxytryptamine uptake stimulant | 0.217 0.121 DBMET03117 0.312 0.039 DBMET03118 | DBMET03118 | |
| 0.009 | 0.394 | 0.064 | Alpha 2 adrenoreceptor agonist | 0.064 0.037 DBMET03118 | DBMET03118 | |
| 0.014 | 0.401 | 0.047 | Kainate receptor agonist | 0.04 0.031 DBMET03117 0.047 0.018 DBMET03118 | DBMET03118 | |
| 0.018 | 0.407 | 0.083 | Dihydroorotate oxidase inhibitor | 0.083 0.009 DBMET03118 | DBMET03118 | |
| 0.034 | 0.423 | 0.134 | Aldehyde dehydrogenase inhibitor | 0.134 0.058 DBMET03118 | DBMET03118 | |
| 0.02 | 0.424 | 0.094 | Myeloperoxidase inhibitor | 0.094 0.042 DBMET03118 | DBMET03118 | |
| 0.009 | 0.414 | 0.067 | Carbamoyl phosphate synthetase inhibitor | 0.067 0.037 DBMET03118 | DBMET03118 | |
| 0.065 | 0.481 | 0.188 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.188 0.083 DBMET03118 | DBMET03118 | |
| 0.015 | 0.436 | 0.048 | Glutamate (mGluR group III) antagonist | 0.048 0.023 DBMET03118 | DBMET03118 | |
| 0.006 | 0.431 | 0.04 | Glutamate (mGluR3) antagonist | 0.04 0.02 DBMET03118 | DBMET03118 | |
| 0.13 | 0.561 | 0.491 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.491 0.038 DBMET03118 | DBMET03118 | |
| 0.002 | 0.437 | 0.02 | Nicotinic acid receptor 1 antagonist | 0.02 0.008 DBMET03118 | DBMET03118 | |
| 0.019 | 0.456 | 0.163 | Creatine kinase inhibitor | 0.163 0.019 DBMET03118 | DBMET03118 | |
| 0.011 | 0.451 | 0.071 | Protein kinase C beta inhibitor | 0.071 0.046 DBMET03118 | DBMET03118 | |
| 0.109 | 0.55 | 0.186 | MAP kinase kinase 3 inhibitor | 0.186 0.168 DBMET03118 | DBMET03118 | |
| 0.008 | 0.455 | 0.071 | Dihydroorotase inhibitor | 0.071 0.011 DBMET03118 | DBMET03118 | |
| 0.027 | 0.475 | 0.193 | Death-associated protein kinase 3 inhibitor | 0.193 0.079 DBMET03118 | DBMET03118 | |
| 0.007 | 0.461 | 0.026 | Glutamate (mGluR1) agonist | 0.026 0.014 DBMET03118 | DBMET03118 | |
| 0.039 | 0.496 | 0.225 | Hexokinase inhibitor | 0.225 0.023 DBMET03118 | DBMET03118 | |
| 0.084 | 0.542 | 0.192 | Nitric-oxide synthase stimulant | 0.192 0.103 DBMET03118 | DBMET03118 | |
| 0.079 | 0.538 | 0.157 | Ca2+-transporting ATPase inhibitor | 0.157 0.028 DBMET03118 | DBMET03118 | |
| 0.021 | 0.48 | 0.113 | Beta glucuronidase inhibitor | 0.113 0.053 DBMET03118 | DBMET03118 | |
| 0.02 | 0.483 | 0.084 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.084 0.057 DBMET03118 | DBMET03118 | |
| 0.005 | 0.471 | 0.033 | Nicotinic acid receptor agonist | 0.033 0.029 DBMET03118 | DBMET03118 | |
| 0.072 | 0.538 | 0.251 | Calcium channel activator | 0.251 0.146 DBMET03117 | DBMET03117 | |
| 0.012 | 0.485 | 0.14 | Alcohol dehydrogenase inhibitor | 0.14 0.024 DBMET03118 | DBMET03118 | |
| 0.006 | 0.481 | 0.051 | Xanthine dehydrogenase inhibitor | 0.051 0.046 DBMET03118 | DBMET03118 | |
| 0.02 | 0.499 | 0.083 | Uric acid excretion stimulant | 0.083 0.078 DBMET03118 | DBMET03118 | |
| 0.003 | 0.491 | 0.02 | Glutamate (mGluR1a) agonist | 0.02 0.019 DBMET03118 | DBMET03118 | |
| 0.024 | 0.515 | 0.085 | MAP kinase kinase 7 inhibitor | 0.085 0.034 DBMET03118 | DBMET03118 | |
| 0.019 | 0.527 | 0.138 | GABA C receptor rho-1 antagonist | 0.138 0.027 DBMET03118 | DBMET03118 | |
| 0.062 | 0.58 | 0.24 | GABA C receptor rho-3 antagonist | 0.24 0.163 DBMET03118 | DBMET03118 | |
| 0.006 | 0.544 | 0.033 | Glutamate (mGluR4) agonist | 0.033 0.025 DBMET03118 | DBMET03118 | |
| 0.019 | 0.583 | 0.148 | Electrolyte absorption antagonist | 0.148 0.02 DBMET03118 | DBMET03118 | |
| 0.004 | 0.583 | 0.092 | Protein kinase (CK2) alpha inhibitor | 0.092 0.084 DBMET03118 | DBMET03118 | |
| 0.006 | 0.586 | 0.031 | Protein kinase (CK2) beta inhibitor | 0.031 0.03 DBMET03118 | DBMET03118 | |
| 0.012 | 0.595 | 0.135 | GABA C receptor antagonist | 0.135 0.04 DBMET03118 | DBMET03118 | |
| 0.015 | 0.624 | 0.071 | Glycine receptor agonist | 0.071 0.052 DBMET03118 | DBMET03118 | |
| 0.008 | 0.635 | 0.042 | Glutamate (mGluR group III) agonist | 0.042 0.031 DBMET03118 | DBMET03118 | |
| 0.029 | 0.708 | 0.191 | RNA-directed DNA polymerase inhibitor | 0.191 0.114 DBMET03118 | DBMET03118 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |